Argenx Se (ARGX) Assets Growth (3y) (2018 - 2026)
Powered by 
Analysis
Argenx Se (ARGX) Assets Growth (3y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.45% |
| Dec 31, 2025 | 40.45% |
| Jun 30, 2025 | 30.22% |
| Dec 31, 2024 | 29.59% |
| Jun 30, 2024 | 14.29% |
| Dec 31, 2023 | 27.05% |
| Jun 30, 2023 | 12.76% |
| Dec 31, 2022 | 25.48% |
| Jun 30, 2022 | 42.04% |
| Dec 31, 2021 | 62.83% |
| Jun 30, 2021 | 95.55% |
| Dec 31, 2020 | 71.81% |
| Jun 30, 2020 | 121.87% |
| Dec 31, 2019 | 140.39% |
| Dec 31, 2018 | 135.77% |
API Access
Argenx Se Assets Growth (3y) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets-growth-3y&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets-growth-3y", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets-growth-3y&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();